259 related articles for article (PubMed ID: 3127423)
21. Early activation marker expression to detect impaired proliferative responses to pokeweed mitogen and tetanus toxoid: studies in patients with AIDS and related disorders.
Prince HE; John JK
Diagn Immunol; 1986; 4(6):306-11. PubMed ID: 3102150
[TBL] [Abstract][Full Text] [Related]
22. Human melanoma cell line M14 secretes a functional interleukin 2.
Alileche A; Plaisance S; Han DS; Rubinstein E; Mingari C; Bellomo R; Jasmin C; Azzarone B
Oncogene; 1993 Jul; 8(7):1791-6. PubMed ID: 8099724
[TBL] [Abstract][Full Text] [Related]
23. Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression.
Reed JC; Abidi AH; Alpers JD; Hoover RG; Robb RJ; Nowell PC
J Immunol; 1986 Jul; 137(1):150-4. PubMed ID: 3011905
[TBL] [Abstract][Full Text] [Related]
24. In vitro activation of T lymphocytes from HIV-seropositive blood donors. II. Decreased mitogen-induced expression of interleukin 2 receptor by both CD4 and CD8 cell subsets.
Prince HE; Czaplicki CD
Clin Immunol Immunopathol; 1988 Aug; 48(2):132-9. PubMed ID: 2968871
[TBL] [Abstract][Full Text] [Related]
25. Induction and regulation of CD2 mRNA in human lymphocytes.
Malter JS; Reed JC; Kamoun M
J Immunol; 1988 May; 140(9):3233-6. PubMed ID: 2896216
[TBL] [Abstract][Full Text] [Related]
26. Interleukin 2 and mitogen driven proliferation in human peripheral mononuclear cells: a kinetic analysis.
Ferrero E; Manfredi A; Bianchi E; Schönheit A; Sabbadini MG; Rugarli C
Haematologica; 1989; 74(4):355-8. PubMed ID: 2507408
[TBL] [Abstract][Full Text] [Related]
27. Thrombin enhances T cell proliferative responses and cytokine production.
Naldini A; Carney DH; Bocci V; Klimpel KD; Asuncion M; Soares LE; Klimpel GR
Cell Immunol; 1993 Apr; 147(2):367-77. PubMed ID: 8453678
[TBL] [Abstract][Full Text] [Related]
28. Age-related decreases in IL-2 production by human T cells are associated with impaired activation of nuclear transcriptional factors AP-1 and NF-AT.
Whisler RL; Beiqing L; Chen M
Cell Immunol; 1996 May; 169(2):185-95. PubMed ID: 8620546
[TBL] [Abstract][Full Text] [Related]
29. Interleukin 2 production, proliferative response, and receptor expression by cord blood mononuclear cells.
Fairfax CA; Borzy MS
J Clin Lab Immunol; 1988 Oct; 27(2):63-7. PubMed ID: 3266760
[TBL] [Abstract][Full Text] [Related]
30. Age-related changes in interleukin 2 responsiveness of resting and activated human mononuclear cells.
Ferrero E; Manfredi A; Bianchi E; Schönheit A; Sabbadini MG; Rugarli C
Haematologica; 1991; 76(1):14-9. PubMed ID: 2055556
[TBL] [Abstract][Full Text] [Related]
31. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
Schmidt RE; Hercend T; Fox DA; Bensussan A; Bartley G; Daley JF; Schlossman SF; Reinherz EL; Ritz J
J Immunol; 1985 Jul; 135(1):672-8. PubMed ID: 3923116
[TBL] [Abstract][Full Text] [Related]
32. Distinct phenotypic and functional characteristics of human natural killer cells obtained by rapid interleukin 2-induced adherence to plastic.
Vujanovic NL; Rabinowich H; Lee YJ; Jost L; Herberman RB; Whiteside TL
Cell Immunol; 1993 Oct; 151(1):133-57. PubMed ID: 8402925
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-2 production by cord blood lymphocytes stimulated with mitogen and in the mixed leukocyte culture.
Hauser GJ; Zakuth V; Rosenberg H; Bino T; Spirer Z
J Clin Lab Immunol; 1985 Jan; 16(1):37-40. PubMed ID: 3156997
[TBL] [Abstract][Full Text] [Related]
34. Compensatory effect of TNFalpha on low natural killer activity in the elderly.
Myśliwska J; Bryl E; Trzonkowski P; Myśliwski A
Acta Biochim Pol; 2000; 47(2):301-11. PubMed ID: 11051195
[TBL] [Abstract][Full Text] [Related]
35. Regulation of interleukin 2 receptor expression: effects of phorbol diester, phospholipase C, and reexposure to lectin or antigen.
Depper JM; Leonard WJ; Krönke M; Noguchi PD; Cunningham RE; Waldmann TA; Greene WC
J Immunol; 1984 Dec; 133(6):3054-61. PubMed ID: 6092466
[TBL] [Abstract][Full Text] [Related]
36. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
[TBL] [Abstract][Full Text] [Related]
37. In vitro activation of T lymphocytes from human immunodeficiency virus (HIV)-seropositive blood donors. I. Soluble interleukin 2 receptor (IL2R) production parallels cellular IL2R expression and DNA synthesis.
Prince HE; Kleinman SH; Maino VC; Jackson AL
J Clin Immunol; 1988 Mar; 8(2):114-20. PubMed ID: 2967306
[TBL] [Abstract][Full Text] [Related]
38. Sodium arsenite-induced inhibition of cell proliferation is related to inhibition of IL-2 mRNA expression in mouse activated T cells.
Conde P; Acosta-Saavedra LC; Goytia-Acevedo RC; Calderon-Aranda ES
Arch Toxicol; 2007 Apr; 81(4):251-9. PubMed ID: 17009048
[TBL] [Abstract][Full Text] [Related]
39. Urokinase receptor. An activation antigen in human T lymphocytes.
Nykjaer A; Møller B; Todd RF; Christensen T; Andreasen PA; Gliemann J; Petersen CM
J Immunol; 1994 Jan; 152(2):505-16. PubMed ID: 8283034
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of action of maternal serum on the interleukin2 receptor expression.
Vanderbeeken YE; Duchateau J; Collet H; Gregoire M; Vandermeersh B; Lucas A
Immunopharmacol Immunotoxicol; 1992; 14(3):491-513. PubMed ID: 1325491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
